期刊文献+

热疗联合胸腔注射香菇多糖治疗恶性胸腔积液的临床观察 被引量:4

下载PDF
导出
摘要 目的探讨热疗联合胸腔内注射香菇多糖治疗恶性胸腔积液的作用机制,观察近期疗效。方法 50例恶性胸腔积液患者,分为单纯组和联合组,均行胸腔闭式引流。单纯组给予胸腔内注射香菇多糖;联合组每次胸腔内注射香菇多糖后30分钟给予射频热疗。结果联合组总有效率为92.3%(24/26),单纯组总有效率为66.7%(16/24),联合组优于单纯组,两组之间差异有显著性;两组治疗前后均未出现血液系统反应及肝、肾功能损害,治疗期间,两组患者仅有少部分出现发热、胸痛等不良反应,两组比较差异无显著性。结论热疗联合胸腔内注射治疗恶性胸腔积液效果好,能明显改善患者生活质量。
机构地区 海军总医院
出处 《中国医刊》 CAS 2012年第11期70-72,共3页 Chinese Journal of Medicine
  • 相关文献

参考文献13

二级参考文献86

共引文献125

同被引文献44

  • 1陈灏珠.实用内科学[M]11版[M].北京:人民卫生出版社,2001.957-959.
  • 2国虹,何威,庞亚萍,李杰.香菇多糖联合顺铂腔内注射治疗恶性胸腹腔积液[J].中国临床医生杂志,2007,35(9):31-31. 被引量:1
  • 3McCormack E,Skavland J, Mujic M,et al. Lentinan: hematopoietic,immunological,and efficacy studies in a syngeneic model of acutemyeloid leukemia[ J]. Nutr Cancer,2010,62(5 ) :574-583.
  • 4Harada K,Itashiki Y,Takenawa T,et al. Effects of lentinan alone andin combination with fluoropyrimidine anticancer agent on growth ofhuman oral squamous cell carcinoma in vitro and in vivo [ J ]. Int JOncol,2010,37(3) :623-631.
  • 5Akazawa N, Taguchi K, Imai A, et al. A case of advanced gastriccancer responding to S-1 /paclitaxel/lentinan as neoadjuvant chemo-immunotherapy[ J ] . Gan To Kagaku Ryoho, 2010, 37 ( 7 ) ' 1365 -1367.
  • 6Nakagawa Y, Yanagawa K, Matsunaga N, et al. A case of gastriccancer with para-aortic lymph node metastasis successfully treatedwith S-1 /paclitaxel/lentinan combination therapy [ J ]. Gan To Ka-gaku Ryoho, 2010,37(6) :1131-1134.
  • 7Yoshino S, Watanabe S, Imano M, et al. Improvement of QOL andprognosis by treatment of superfine dispersed lentinan in patients withadvanced gastric cancer[ J]. Hepatogastroenterology ,2010,57 (97 ) .172-177.
  • 8Ostrowski MJ. An assessment of the long-term results of controlling the reaccumulation of malignant effusions using intracavity bleomycin [ J ]. Cancer, 1986 (5) :721-727.
  • 9Yamaguchi M, Ichinose Y, Shimamatsu S, et al.Preoperative concurrent chemoradiotherapy followed by extrapleural pneumonectomy for patients with non-small cell lung cancer with malignant pleural effusion and/or pleural nodules: Ten-year results of a prematurely terminated single institute phase II trial[J]. Surg Oncol, 2015, 24(2):78-83.
  • 10Eisenhauer EA, Therasse P, Boqaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline[J]. Eur J Cancer, 2009, 45(2):228-247.

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部